Public invited to comment on Early and locally advanced breast cancer draft NICE guideline update
Consultation is now open on the update to National Institute for Health and Care Excellence (NICE) guideline Early and locally advanced breast cancer: diagnosis and management.
This guideline covers the diagnosis and management of early and locally advanced breast cancer. The guideline covers people aged 18 and over with: newly diagnosed adenocarcinoma of the breast of any size (T1 – T4), with or without spread to locoregional lymph nodes (N0 – N3) and with no distant metastases (M0); newly diagnosed ductal carcinoma in situ (DCIS); and Paget’s disease of the breast.
The guideline aims to improve care for people with early and locally advanced breast cancer by recommending people receive the most effective treatment for their cancer.
The areas updated as part of this guideline update are:
- Surgery to the breast
- Management of the positive axilla
- Adjuvant systemic therapy planning
- Endocrine therapy for invasive disease
- Adjuvant chemotherapy
- Adjuvant biological therapy
- Adjuvant bisphosphonates
- Breast radiotherapy
- Post-mastectomy radiotherapy
- Neoadjuvant treatment of early and locally advanced breast cancer
The guideline and associated documents are now available on the NICE website and stakeholder consultation on the draft guidance will close on Tuesday 6 March 2018.
To find out more about the draft guidance, register as a stakeholder, or to submit comments, please visit the NICE website.